Drug recall · August 14, 2013
BuPROPion Hydrochloride Extended-Release Tablets recall
Why: Failed Dissolution Specifications: Dissolution test results at 8 hour time-point were above approved specification limits.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
BuPROPion Hydrochloride Extended-Release Tablets (XL), 300 mg, 30-count tablets per bottle, Rx only, Distributed by: Actavis South Atlantic, LLC, Sunrise, FL 33325; Packaged by: American Health Packaging, Columbus, OH 43217, NDC 67767-142-30, UPC 3 67767-142-30 6.
- Lots / codes
Lot #: CG2D18A, Exp 06/14
- Quantity
- 15,132 bottles
- Company
- Actavis Inc, Parsippany, NJ
- Distribution
- Nationwide and Puerto Rico
- Initiated
- July 31, 2013 · Voluntary: Firm initiated
- Classified
- August 8, 2013
- Reported
- August 14, 2013
- Ended
- May 9, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Bupropion
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.